Literature DB >> 26468712

Levosimendan for Septic Myocardial Dysfunction: Not Yet Ready for Prime Time.

Diana Pang1, Rajesh K Aneja.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26468712      PMCID： PMC4610248          DOI： 10.1097/CCM.0000000000001328

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  20 in total

Review 1.  HMGB1 as a late mediator of lethal systemic inflammation.

Authors:  H Wang; H Yang; C J Czura; A E Sama; K J Tracey
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

2.  Left ventricular systolic and diastolic function in septic shock.

Authors:  J Poelaert; C Declerck; D Vogelaers; F Colardyn; C A Visser
Journal:  Intensive Care Med       Date:  1997-05       Impact factor: 17.440

3.  Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.

Authors:  Andrea Morelli; Stefano De Castro; Jean-Louis Teboul; Mervyn Singer; Monica Rocco; Giorgio Conti; Leonardo De Luca; Emanuele Di Angelantonio; Alessandra Orecchioni; Natesa G Pandian; Paolo Pietropaoli
Journal:  Intensive Care Med       Date:  2005-04-06       Impact factor: 17.440

4.  A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance.

Authors:  J E Parrillo; C Burch; J H Shelhamer; M M Parker; C Natanson; W Schuette
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

5.  Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right-ventricular papillary muscles and indo-1-loaded single ventricular cardiomyocytes of the rabbit.

Authors:  S Sato; M A Talukder; H Sugawara; H Sawada; M Endoh
Journal:  J Mol Cell Cardiol       Date:  1998-06       Impact factor: 5.000

Review 6.  Role of levosimendan in sepsis and septic shock.

Authors:  Bernardo Bollen Pinto; Sebastian Rehberg; Christian Ertmer; Martin Westphal
Journal:  Curr Opin Anaesthesiol       Date:  2008-04       Impact factor: 2.706

7.  Effects of levosimendan on flow-mediated vasodilation and soluble adhesion molecules in patients with advanced chronic heart failure.

Authors:  John T Parissis; Apostolos Karavidas; Vassiliki Bistola; Sophia Arapi; Ioannis A Paraskevaidis; Dimitrios Farmakis; Dimitrios Korres; Gerasimos Filippatos; Evaggelos Matsakas; Dimitrios T Kremastinos
Journal:  Atherosclerosis       Date:  2007-06-12       Impact factor: 5.162

8.  Actual incidence of global left ventricular hypokinesia in adult septic shock.

Authors:  Antoine Vieillard-Baron; Vincent Caille; Cyril Charron; Guillaume Belliard; Bernard Page; François Jardin
Journal:  Crit Care Med       Date:  2008-06       Impact factor: 7.598

9.  Rho kinase regulates induction of T-cell immune dysfunction in abdominal sepsis.

Authors:  Z Hasan; K Palani; S Zhang; M Lepsenyi; R Hwaiz; M Rahman; I Syk; B Jeppsson; Henrik Thorlacius
Journal:  Infect Immun       Date:  2013-04-29       Impact factor: 3.441

10.  Effects of levo- and dextrosimendan on NF-kappaB-mediated transcription, iNOS expression and NO production in response to inflammatory stimuli.

Authors:  O Sareila; R Korhonen; H Auvinen; M Hämäläinen; H Kankaanranta; E Nissinen; E Moilanen
Journal:  Br J Pharmacol       Date:  2008-08-18       Impact factor: 8.739
View more
  1 in total

1.  Effect of levosimendan on mortality in severe sepsis and septic shock: a meta-analysis of randomised trials.

Authors:  Wei Chang; Jian-Feng Xie; Jing-Yuan Xu; Yi Yang
Journal:  BMJ Open       Date:  2018-03-30       Impact factor: 2.692
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.